Dr Samantha Cruz Rivera

Dr Samantha Cruz Rivera

Institute of Applied Health Research
Research Fellow, Centre for Patient Reported Outcomes
Research Fellow at Demand Hub

Contact details

Telephone
+44 0121 414 3354
Email
s.rivera@bham.ac.uk
Twitter
@samsamcr
Address
Centre for Patient Reported Outcomes Research (CPROR)
Institute of Applied Health Research
The Murray Learning Centre
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Samantha Cruz Rivera, PhD, has expertise in the design and analysis of Delphi methodology, systematic reviews, surveys and co-designing research with patient advocates and members of the public. Her main research interests are assessment of patient reported outcomes (PROs) and maximising the impact of PROs from clinical trials. Other research interests include artificial intelligence and regulatory science.

Dr Cruz Rivera is a research fellow at the Centre for Patient Reported Outcomes (PROs) Research which aims to optimize the use of PROs in clinical trials and routine care, to improve service delivery, enhance patient care and outcomes and ensure that the patient perspective is at the heart of health research and NHS decision-making.

Dr Cruz Rivera is also a research fellow at the Demand Hub (Data-Enabled Medical technologies ANd Devices Hub), which aims at providing support to small and medium enterprises around business development, digital tech, validation and commercialisation, clinical studies and trials and; clinician/expert/user experience.

Qualifications

  • PhD in Primary Care & Clinical Science, University of Birmingham, 2019
  • MSc Health economics & Health policy, University of Birmingham, 2014
  • BSc (Hons) in Economics, Universidad Nacional Autónoma de México, 2012

Publications

  • Cruz Rivera, S., Mercieca-Bebber, R., Aiyegbusi, O.L. et al. The need for ethical guidance for the use of patient-reported outcomes in research and clinical practice. Nat Med (2021). https://doi.org/10.1038/s41591-021-01275-z
  • Cruz Rivera, S., Torlinska, B., Marston, E. et al. Advancing UK Regulatory Science Strategy in the Context of Global Regulation: a Stakeholder Survey. Ther Innov Regul Sci (2021). https://doi.org/10.1007/s43441-021-00263-2
  • Cruz Rivera, S., Liu, X., Chan, AW. et al. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension. Nat Med26, 1351–1363 (2020). https://doi.org/10.1038/s41591-020-1037-7
  • Liu, X., Cruz Rivera, S., Moher, D. et al. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Nat Med26, 1364–1374 (2020). https://doi.org/10.1038/s41591-020-1034-x
  • Cruz Rivera, S., McMullan, C., Jones, L. et al. The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders. J Patient Rep Outcomes 4, 51 (2020). https://doi.org/10.1186/s41687-020-00219-4
  • Rivera, S.C., Kyte, D.G., Aiyegbusi, O.L. et al. The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis. Health Qual Life Outcomes 17, 156 (2019). https://doi.org/10.1186/s12955-019-1220-z
  • Liu, X., Rivera, S.C., Faes, L. et al. Reporting guidelines for clinical trials evaluating artificial intelligence interventions are needed. Nat Med 25, 1467–1468 (2019). https://doi.org/10.1038/s41591-019-0603-3
  • Cruz Rivera S, Kyte DG, Aiyegbusi OL, Keeley TJ, Calvert MJ (2017) Assessing the impact of healthcare research: A systematic review of methodological frameworks. PLoS Med 14(8): e1002370. https://doi.org/10.1371/journal. pmed.1002370